Home/Filings/4/0001209191-22-031879
4//SEC Filing

Wentworth Kerry 4

Accession 0001209191-22-031879

CIK 0001811063other

Filed

May 24, 8:00 PM ET

Accepted

May 25, 4:36 PM ET

Size

7.8 KB

Accession

0001209191-22-031879

Insider Transaction Report

Form 4
Period: 2022-05-23
Wentworth Kerry
CHIEF REGULATORY OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-05-23+330,000330,000 total
    Exercise: $3.78Exp: 2032-05-22Common Stock (330,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2022-05-23+247,500247,500 total
    Exercise: $3.78Exp: 2032-05-22Common Stock (247,500 underlying)
Footnotes (2)
  • [F1]Option vests as to 25% on the one year anniversary of 5/23/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
  • [F2]The shares subject to the Options will vest based on the satisfaction of both time-based and performance-based vesting criteria.

Issuer

Nuvation Bio Inc.

CIK 0001811063

Entity typeother

Related Parties

1
  • filerCIK 0001369453

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 4:36 PM ET
Size
7.8 KB